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Hyponatremia with hyperkalemia in infancy is a rare presentation, but may be due to aldosterone
deﬁciency or end organ resistance to its action. There are few cases associating this condition with
urinary tract infections or anatomic abnormalities that predispose to infection. Clinicians should have a
high index of suspicion in diagnosing secondary pseudohypoaldosteronism (PHA) due to its often
atypical presentation. We describe ten month-old infant who presented with this condition and was
found to have urinary tract infection complicating unilateral urinary tract anomaly, which may have
strong association with renal tubular resistance to aldosterone.
 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Hyponatremia with hyperkalemia is uncommon in infancy, but
is a medical emergency that can cause life-threatening cardiac
arrhythmias. These abnormalities may be due to congenital adrenal
hyperplasia (CAH) that results from lack of 11- or 21-hydroxylase
which are required for the synthesis of the mineralocorticoid,
aldosterone. Other causes for impaired mineralocorticoid secretion
or response may exist, particularly in infants one month of age or
older. Such causes are PHA, congenital adrenal hypoplasia, isolated
aldosterone deﬁciency and medication.1 PHA is classiﬁed into Type
1 and Type 2, which is characterized by hypertension and hyper-
kalemia. Type 1 is further sub-classiﬁed into primary and secondary
(transient) PHA. The underlying pathology in Type 1 primary PHA is
mutation in the amiloride-sensitive epithelial sodium channel gene
or mineralocorticoid receptor mutation.1,2 This causes end organ
resistance to mineralocorticoids. Type 1 secondary (transient) PHA
is strongly associated with urinary tract infections (UTI) compli-
cating structural urinary tract anomalies.3,4 We report an infant
who presented with profound hyponatremia in the setting of uri-
nary infection accompanied by structural abnormalities of theInc. This is an open access article uurinary tract. Subsequent to antibiotic therapy that cleared the
infection, the electrolyte disturbances resolved, and required no
ongoing therapy. We attribute these ﬁndings to Type 1 secondary
(transient) PHA. The case demonstrates that the strongest predis-
position for the development of aldosterone resistance or second-
ary PHA is the existence of severe urinary tract infection5 or more
frequently urinary infection complicating structural urinary tract
anomalies.Case presentaion
A 10 month-old girl with an unremarkable birth history
presented with failure to thrive. Investigation revealed a sodium of
103 mmol/L, potassium 6 mmol/L. She had a non-anionic gap,
metabolic acidosis and her transtubular potassium gradient (TTKG)
was < 3 (normal 8 e 9) indicating reduced urinary potassium
excretion. The urine sodiumwas< 25 mmol/L. Infusion of 3% saline
partially corrected the hyponatremia. With the addition of
ﬂudrocortisone her electrolytes normalized within 24 h.
Urinalysis revealed leukocytes and nitrites. Escherichia coli
was isolated from the urine culture. 21-hydroxylase and cortisol
were normal. Aldosterone was elevated at 308.3 ng/dL (normal
5 e 80 ng/dL), implying tubular unresponsiveness. Renal imag-
ing detected a duplicated left collecting system (Fig. 1) with an
upper pole ectopic ureter that extended to the bladder neck andnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Renal ultrasonography showing duplicated left collecting system.
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two days and discharged home on amoxicillin/clavulanate for
two weeks. In the ensuing months, she tolerated weaning from
ﬂudrocortisone without recurrence of the electrolyte distur-
bances. Later, an upper pole nephroureterectomy was per-
formed. Subsequent growth has been normal.
Discussion
The primary function of aldosterone is reabsorption of sodium
and water at the expense of potassium in the distal renal tubule.
Deﬁciency of aldosterone or end organ resistance to its actions
leads to hyponatremia, hypovolemia, hyperkalemia and metabolic
acidosis. The key ﬁnding in Type 1 PHA is an elevated serum
aldosterone level with hyponatremia and hyperkalemia. One
should have a high index of suspicion for this diagnosis especially in
infants. The least rare cause for Type I PHA is CAH due to 11- or 21-
hydroxylase deﬁciency. Still rarer are congenital adrenal hypoplasia
and isolated aldosterone deﬁciency. PHA can occur with nephro-
toxic medications such as angiotensin converting enzyme
inhibitors, non-steroidal anti-inﬂammatory drugs and beta-
blockers.1,4 Today almost all states include CAH in the newborn
metabolic screen. Type 1 secondary (transient) PHA is strongly
associated with urinary tract infections in the setting of urinary
anomalies,3 which differentiates it from Type 1 (genetic) PHA. Our
patient’s UTI with renal anomaly, a unilateral defect, makes the
ﬁnding of PHA especially surprising. There are, however, several
reports of transient PHA in infancy, some of which also had uni-
lateral disease. Nandagopal et al.,1 reported four infants with failure
to thrive, hyponatremia, hyperkelemia and unilateral renalanomalies with urinary infections. These patients, like our patient,
exhibited transient renal tubular resistance to mineralocorticoids.
We speculate that severe renal inﬂammation may cause transient
tubular resistance to aldosterone independent of structural anom-
aly.5 Also, the fact that addition of ﬂudrocortisone in our patient
causes rapid correction of electrolytes implies that high levels of
mineralocorticoids may overcome transient tubular resistance.
Our patient demonstrated that renal tubular resistance to
aldosterone can be caused by a urinary tract infection complicating
congenital urinary tract anomalies. In the setting of an infant with
hyponatremia, serum aldosterone, urine sodium, and urine cultures
should be obtained. Renal imaging (ultrasound) is indicated in
children under age six months with atypical UTI irrespective of type
1 PHA and in children over six months old who have a UTI and type
1 PHA.4
Conclusion
1) Transient PHA should be considered in infants presenting with
hyponatremia and hyperkalemia, even though genetic CAH has
been excluded on newborn metabolic screening.
2) Urinary tract infection may occur without fever.
3) Evaluation of an infant with urinary tract infection should
include serum electrolytes.
4) Urinary tract imaging is indicated in children aged less than six
months with atypical UTI irrespective of Type 1 PHA and in
children over age six months with a UTI and Type 1 PHA.Consent
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